Dr. John Anderson, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $384,222 | 196 | 45.5% |
| Consulting Fee | $192,912 | 65 | 22.8% |
| Honoraria | $169,416 | 77 | 20.1% |
| Travel and Lodging | $44,739 | 154 | 5.3% |
| Food and Beverage | $35,157 | 1,234 | 4.2% |
| Unspecified | $18,048 | 12 | 2.1% |
| Education | $217.51 | 11 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Behring | $221,364 | 387 | $0 (2024) |
| Pharming Healthcare, Inc. | $146,178 | 164 | $0 (2024) |
| Shire North American Group Inc | $128,450 | 182 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $107,519 | 146 | $0 (2024) |
| GlaxoSmithKline, LLC. | $88,903 | 186 | $0 (2024) |
| BioCryst US Sales Co., LLC | $55,376 | 51 | $0 (2024) |
| Blueprint Medicines Corporation | $25,286 | 50 | $0 (2024) |
| BioCryst Pharmaceuticals, Inc. | $22,322 | 29 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20,674 | 12 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $8,012 | 155 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $161,331 | 296 | CSL Behring ($75,570) |
| 2023 | $139,455 | 271 | Takeda Pharmaceuticals U.S.A., Inc. ($40,824) |
| 2022 | $88,627 | 232 | CSL Behring ($22,369) |
| 2021 | $100,541 | 200 | CSL Behring ($29,963) |
| 2020 | $84,968 | 173 | CSL Behring ($22,601) |
| 2019 | $94,988 | 216 | Shire North American Group Inc ($40,183) |
| 2018 | $88,062 | 179 | Shire North American Group Inc ($49,720) |
| 2017 | $86,740 | 182 | Shire North American Group Inc ($38,547) |
All Payment Transactions
1,749 individual payment records from CMS Open Payments — Page 1 of 70
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | CSL Behring | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| 12/19/2024 | CSL Behring | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $1,329.50 | General |
| 12/19/2024 | CSL Behring | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $354.80 | General |
| 12/19/2024 | CSL Behring | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $147.50 | General |
| 12/17/2024 | CSL Behring | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $2,645.10 | General |
| 12/17/2024 | CSL Behring | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $629.30 | General |
| 12/17/2024 | CSL Behring | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $566.40 | General |
| 12/17/2024 | CSL Behring | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $426.10 | General |
| 12/17/2024 | CSL Behring | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $415.30 | General |
| 12/17/2024 | CSL Behring | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $147.50 | General |
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Respiratory | ||||||
| 12/13/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: Immunology | ||||||
| 12/12/2024 | CSL Behring | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,250.00 | General |
| 12/12/2024 | CSL Behring | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| 12/12/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/09/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/09/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $8.58 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $33.96 | General |
| Category: Oncology / Rare Diseases | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Honoraria | Cash or cash equivalent | $868.00 | General |
| Category: Oncology / Rare Diseases | ||||||
| 12/02/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Immunology | ||||||
| 12/02/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| COPD pragmatic randomised clinical trial | Boehringer Ingelheim Pharmaceuticals, Inc. | $15,000 | 1 |
| An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis | Regeneron Pharmaceuticals, Inc. | $2,148 | 3 |
| An Open-label Study to Evaluate the Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema | CSL Behring | $491.16 | 2 |
| A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTICENTER, STRATIFIED ST | GlaxoSmithKline, LLC. | $408.14 | 6 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 476 | 12,309 | $604,771 | $312,042 |
| 2022 | 13 | 388 | 12,054 | $454,250 | $292,842 |
| 2021 | 11 | 303 | 10,450 | $408,674 | $266,492 |
| 2020 | 15 | 435 | 13,063 | $485,515 | $311,608 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2357 | Injection, omalizumab, 5 mg | Office | 2023 | 21 | 8,970 | $509,130 | $269,987 | 53.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 123 | 202 | $26,462 | $17,108 | 64.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $8,505 | $5,078 | 59.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 34 | 399 | $10,374 | $3,750 | 36.1% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 24 | 1,180 | $9,440 | $3,194 | 33.8% |
| 95044 | Test for allergy using skin patch | Office | 2023 | 14 | 849 | $12,735 | $2,942 | 23.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 18 | $3,564 | $2,288 | 64.2% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 49 | 79 | $6,636 | $1,447 | 21.8% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 15 | 144 | $2,304 | $1,383 | 60.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 18 | 20 | $2,620 | $1,291 | 49.3% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 26 | 195 | $7,917 | $1,278 | 16.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 19 | $1,805 | $1,261 | 69.9% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2023 | 11 | 96 | $1,536 | $537.41 | 35.0% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 24 | 29 | $783.00 | $377.87 | 48.3% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 40 | 64 | $960.00 | $119.07 | 12.4% |
| J2357 | Injection, omalizumab, 5 mg | Office | 2022 | 14 | 8,627 | $370,961 | $256,997 | 69.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 98 | 132 | $17,292 | $11,914 | 68.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 58 | 58 | $10,962 | $6,704 | 61.2% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 34 | 1,512 | $12,096 | $4,457 | 36.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 25 | 367 | $9,542 | $3,756 | 39.4% |
| 95044 | Test for allergy using skin patch | Office | 2022 | 13 | 715 | $10,725 | $2,375 | 22.1% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 16 | 198 | $9,471 | $1,560 | 16.5% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 14 | 121 | $1,936 | $1,327 | 68.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 15 | 16 | $2,096 | $1,232 | 58.8% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 42 | 61 | $5,124 | $1,167 | 22.8% |
About Dr. John Anderson, M.D
Dr. John Anderson, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Homewood, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1154543452.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Anderson, M.D has received a total of $844,711 in payments from pharmaceutical and medical device companies, with $161,331 received in 2024. These payments were reported across 1,749 transactions from 44 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($384,222).
As a Medicare-enrolled provider, Anderson has provided services to 1,602 Medicare beneficiaries, totaling 47,876 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Pediatrics, Pulmonary Disease
- Location Homewood, AL
- Active Since 05/03/2007
- Last Updated 03/11/2016
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1154543452
Products in Payments
- RUCONEST (Biological) $139,725
- CINRYZE (Drug) $138,434
- Haegarda (Biological) $98,830
- NUCALA (Biological) $85,869
- TAKHZYRO (Biological) $64,429
- ORLADEYO (Drug) $36,224
- Orladeyo (Drug) $23,191
- AYVAKIT (Drug) $20,222
- Hizentra (Biological) $13,054
- Privigen (Biological) $10,654
- JOENJA (Drug) $6,421
- FIRAZYR (Drug) $5,401
- AIRSUPRA (Drug) $5,255
- CINQAIR (Drug) $4,583
- DUPIXENT DUPILUMAB INJECTION (Biological) $2,213
- NITYR (Drug) $1,851
- SPIRIVA RESPIMAT (Drug) $1,576
- DUPIXENT (Biological) $1,390
- TRELEGY ELLIPTA (Drug) $937.87
- Xolair (Biological) $926.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Homewood
Tyler Poston, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $6,660
Jacob Langston, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $413.80
Michael Anderson, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $293.06
Dr. Amanda Bowden, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $218.58
Karl Black
Student in an Organized Health Care Education/Training Program
Kalei Graham
Student in an Organized Health Care Education/Training Program